Institutional & Insider Ownership
44.3% of shares of all “Electromedical equipment” companies are owned by institutional investors. 56.5% of Yubo International Biotech shares are owned by company insiders. Comparatively, 15.3% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Risk and Volatility
Yubo International Biotech has a beta of 3.09, suggesting that its stock price is 209% more volatile than the S&P 500. Comparatively, Yubo International Biotech’s peers have a beta of 16.47, suggesting that their average stock price is 1,547% more volatile than the S&P 500.
Profitability
This table compares Yubo International Biotech and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Yubo International Biotech | -274.96% | N/A | -121.41% |
| Yubo International Biotech Competitors | -299.60% | -764.44% | -27.12% |
Valuation and Earnings
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Yubo International Biotech | $610,000.00 | -$1.20 million | -8.61 |
| Yubo International Biotech Competitors | $1.02 billion | $83.13 million | 9.17 |
Yubo International Biotech’s peers have higher revenue and earnings than Yubo International Biotech. Yubo International Biotech is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Summary
Yubo International Biotech peers beat Yubo International Biotech on 6 of the 9 factors compared.
About Yubo International Biotech
Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.
Receive News & Ratings for Yubo International Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yubo International Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
